Rossari Biotech Limited (NSE:ROSSARI)

Rossari Biotech Statistics

Total Valuation

Rossari Biotech has a market cap or net worth of INR 29.55 billion. The enterprise value is 32.31 billion.

Market Cap	29.55B
Enterprise Value	32.31B

Important Dates

The last earnings date was Saturday, January 17, 2026.

Earnings Date	Jan 17, 2026
Ex-Dividend Date	Jun 20, 2025

Share Statistics

Rossari Biotech has 55.38 million shares outstanding. The number of shares has increased by 0.10% in one year.

Current Share Class	55.38M
Shares Outstanding	55.38M
Shares Change (YoY)	+0.10%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	53.48%
Owned by Institutions (%)	17.98%
Float	17.64M

Valuation Ratios

The trailing PE ratio is 21.47 and the forward PE ratio is 19.13. Rossari Biotech's PEG ratio is 1.53.

PE Ratio	21.47
Forward PE	19.13
PS Ratio	1.29
PB Ratio	2.36
P/TBV Ratio	2.90
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	1.53

Enterprise Valuation

EV / Earnings	23.46
EV / Sales	1.41
EV / EBITDA	12.25
EV / EBIT	16.56
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.28
Debt / EBITDA	1.34
Debt / FCF	n/a
Interest Coverage	7.75

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	9.38%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	5.33%
Revenue Per Employee	42.82M
Profits Per Employee	2.57M
Employee Count	535
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Rossari Biotech has paid 482.88 million in taxes.

Income Tax	482.88M
Effective Tax Rate	25.96%

Stock Price Statistics

The stock price has decreased by -29.65% in the last 52 weeks. The beta is 0.20, so Rossari Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.20
52-Week Price Change	-29.65%
50-Day Moving Average	580.38
200-Day Moving Average	644.55
Relative Strength Index (RSI)	36.12
Average Volume (20 Days)	63,668

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Rossari Biotech had revenue of INR 22.91 billion and earned 1.38 billion in profits. Earnings per share was 24.85.

Revenue	22.91B
Gross Profit	7.10B
Operating Income	1.94B
Pretax Income	1.86B
Net Income	1.38B
EBITDA	2.57B
EBIT	1.94B
Earnings Per Share (EPS)	24.85

Balance Sheet

The company has 767.93 million in cash and 3.53 billion in debt, with a net cash position of -2.76 billion or -49.81 per share.

Cash & Cash Equivalents	767.93M
Total Debt	3.53B
Net Cash	-2.76B
Net Cash Per Share	-49.81
Equity (Book Value)	12.51B
Book Value Per Share	226.03
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 31.01%, with operating and profit margins of 8.45% and 6.01%.

Gross Margin	31.01%
Operating Margin	8.45%
Pretax Margin	8.12%
Profit Margin	6.01%
EBITDA Margin	11.20%
EBIT Margin	8.45%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.09%.

Dividend Per Share	0.50
Dividend Yield	0.09%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.10%
Shareholder Yield	-0.00%
Earnings Yield	4.66%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2